2022, in collaboration with Dr. Brinton, we launched an NIH-sponsored, randomized, placebo-controlled clinical trial (read, a very thorough clinical trial) to test PhytoSERM for support of brain energy and cognitive function in perimenopausal and early menopausal women. This launch shows exciting promise. With clinical validation, we are hoping this estrogenic formulation will prove valuable not only to address the symptoms of menopause but also to provide extra protection for our brains, shielding them against dementia in particular. The trial results should be available around 2025, which,
...more
